S.V. Deshpande
About
In The Last Decade
S.V. Deshpande
17 papers receiving 336 citations
Peers
Comparison fields: 5 of 57
- Radiology, Nuclear Medicine and Imaging 227
- Oncology 110
- Molecular Biology 74
- Immunology 66
- Pulmonary and Respiratory Medicine 49
Countries citing papers authored by S.V. Deshpande
This map shows the geographic impact of S.V. Deshpande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.V. Deshpande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.V. Deshpande more than expected).
Fields of papers citing papers by S.V. Deshpande
This network shows the impact of papers produced by S.V. Deshpande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.V. Deshpande. The network helps show where S.V. Deshpande may publish in the future.
Co-authorship network of co-authors of S.V. Deshpande
This figure shows the co-authorship network connecting the top 25 collaborators of S.V. Deshpande. A scholar is included among the top collaborators of S.V. Deshpande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.V. Deshpande. S.V. Deshpande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 16 | |
| 3 | 5 | |
| 4 | 13 | |
| 5 | 9 | |
| 6 | 11 | |
| 7 | 27 | |
| 8 | 22 | |
| 9 | Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo. | 45 |
| 10 | Macrocyclic chelates of radiometals for diagnosis and therapy. | 48 |
| 11 | Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. | 127 |
| 12 | 1 | |
| 13 | 13 | |
| 14 | 1 | |
| 15 | 6 | |
| 16 | 14 | |
| 17 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.